Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144

  • Original Article
  • Published:
Tumor Biology

This article was retracted on 20 April 2017

Abstract

Activating protein-4 (AP4) has been recently shown to regulate the cancer metastases in some cancers including non-small cell lung cancer (NSCLC). Specifically, AP4 regulates mTor/p21 and transforming growth factor β (TGFβ) receptor signaling pathway to increase an epithelial-mesenchymal transition process to augment cell invasiveness. Nevertheless, how AP4 is regulated in NSCLC has not been studied. Here, we showed that in the specimens from the NSCLC patients, the levels of miR-144 were significantly decreased and the levels of AP4 were significantly increased, compared to the paired non-tumor lung tissue. The levels of miR-144 and AP4 inversely correlated in patients’ specimens. Bioinformatics analyses revealed that miR-144 targeted the 3′-UTR of AP4 mRNA to inhibit its translation, confirmed by luciferase-reporter assay. Moreover, miR-144 overexpression inhibited AP4-mediated cell invasiveness, while miR-144 depletion increased AP4-mediated cell invasiveness in NSCLC cells. Together, our data suggest that miR-144 suppression may be the cause of the increased levels of AP4, as well as the augmented cancer metastases, in NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mitsudomi T, Suda K, Yatabe Y. Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol. 2013;10:235–44.

    Article  CAS  PubMed  Google Scholar 

  2. Pallis AG, Syrigos KN. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC. Lung Cancer. 2013;80:120–30.

    Article  CAS  PubMed  Google Scholar 

  3. Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5:S389–96.

    PubMed  PubMed Central  Google Scholar 

  4. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits growth of non-small cell lung cancer in vitro and in vivo. Cell Signal. 2015;27:1208–13.

    Article  CAS  PubMed  Google Scholar 

  5. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits mmp9 to prevent metastasis of non-small cell lung cancer. Tumour Biol. 2014;35:11051–6.

    Article  CAS  PubMed  Google Scholar 

  6. Liu G, Xu S, Jiao F, Ren T, Li Q. Vascular endothelial growth factor b coordinates metastasis of non-small cell lung cancer. Tumour Biol. 2015;36:2185–91.

    Article  CAS  PubMed  Google Scholar 

  7. Lv Q, Shen R, Wang J. RBPJ inhibition impairs the growth of lung cancer. Tumour Biol. 2015;36:3751–6.

    Article  CAS  PubMed  Google Scholar 

  8. Pei J, Lou Y, Zhong R, Han B. MMP9 activation triggered by epidermal growth factor induced foxo1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35:6673–8.

    Article  CAS  PubMed  Google Scholar 

  9. Zhao D, Lu Y, Yang C, Zhou X, Xu Z. Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer. Tumour Biol. 2015;36:3637–42.

    Article  CAS  PubMed  Google Scholar 

  10. Bernardini N, Giannessi F, Bianchi F, Dolfi A, Lupetti M, Citti L, et al. Involvement of basic fibroblast growth factor in suramin-induced inhibition of v79/AP4 fibroblast cell proliferation. Br J Cancer. 1993;67:1209–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shi L, Jackstadt R, Siemens H, Li H, Kirchner T, Hermeking H. P53-induced mir-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res. 2014;74:532–42.

    Article  CAS  PubMed  Google Scholar 

  12. Jackstadt R, Jung P, Hermeking H. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation. Cell Death Dis. 2013;4:e775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jackstadt R, Roh S, Neumann J, Jung P, Hoffmann R, Horst D, et al. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med. 2013;210:1331–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Jackstadt R, Hermeking H. AP4 is required for mitogen- and c-myc-induced cell cycle progression. Oncotarget. 2014;5:7316–27.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jung P, Menssen A, Mayr D, Hermeking H. AP4 encodes a c-myc-inducible repressor of p21. Proc Natl Acad Sci U S A. 2008;105:15046–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Goc A, Al-Azayzih A, Abdalla M, Al-Husein B, Kavuri S, Lee J, et al. P21 activated kinase-1 (pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor beta expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem. 2013;288:3025–35.

    Article  CAS  PubMed  Google Scholar 

  17. Chiang YA, Shao W, Xu XX, Chernoff J, Jin T. P21-activated protein kinase 1 (pak1) mediates the cross talk between insulin and beta-catenin on proglucagon gene expression and its ablation affects glucose homeostasis in male c57bl/6 mice. Endocrinology. 2013;154:77–88.

    Article  CAS  PubMed  Google Scholar 

  18. Gong H, Han S, Yao H, Zhao H, Wang Y. AP4 predicts poor prognosis in nonsmall cell lung cancer. Mol Med Rep. 2014;10:336–40.

    CAS  PubMed  Google Scholar 

  19. Wang W, Wu X, Tian Y. Crosstalk of AP4 and TGFbeta receptor signaling in NSCLC. Tumour Biol. 2015;36:447–52.

    Article  CAS  PubMed  Google Scholar 

  20. Mei Q, Li F, Quan H, Liu Y, Xu H. Busulfan inhibits growth of human osteosarcoma through mir-200 family microRNAs in vitro and in vivo. Cancer Sci. 2014;105:755–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Chang Y, Zhao Y, Gu W, Cao Y, Wang S, Pang J, et al. Bufalin inhibits the differentiation and proliferation of cancer stem cells derived from primary osteosarcoma cells through mir-148a. Cell Physiol Biochem. 2015;36:1186–96.

    Article  CAS  PubMed  Google Scholar 

  22. Ji D, Li B, Shao Q, Li F, Li Z, Chen G. MiR-22 suppresses BMP7 in the development of cirrhosis. Cell Physiol Biochem. 2015;36:1026–36.

    Article  CAS  PubMed  Google Scholar 

  23. Song W, Li Q, Wang L, Wang L. Modulation of foxo1 expression by mir-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem. 2015;35:184–90.

    Article  CAS  PubMed  Google Scholar 

  24. Wang Q, Cai J, Wang J, Xiong C, Zhao J. Mir-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Tumour Biol. 2014;35:12743–8.

    Article  CAS  PubMed  Google Scholar 

  25. Leva G, Croce CM. MiRNA profiling of cancer. Curr Opin Genet Dev. 2013;23:3–11.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18:282–9.

    Article  CAS  PubMed  Google Scholar 

  27. Cao T, Li H, Hu Y, Ma D, Cai X. Mir-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting e2f3. Tumour Biol. 2014;35:10759–64.

    Article  CAS  PubMed  Google Scholar 

  28. Guan H, Liang W, Xie Z, Li H, Liu J, Liu L, et al. Down-regulation of mir-144 promotes thyroid cancer cell invasion by targeting zeb1 and zeb2. Endocrine. 2015;48:566–74.

    Article  CAS  PubMed  Google Scholar 

  29. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, et al. Mir-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 2013;280:4531–8.

    Article  CAS  PubMed  Google Scholar 

  30. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, et al. Downregulation of mir-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis. 2012;33:2391–7.

    Article  CAS  PubMed  Google Scholar 

  31. Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, et al. Clinical significance of mir-144-zfx axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer. 2012;107:1345–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kalimutho M, Del Vecchio Blanco G, Di Cecilia S, Sileri P, Cretella M, Pallone F, et al. Differential expression of mir-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol. 2011;46:1391–402.

    Article  CAS  PubMed  Google Scholar 

  33. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417–23.

    Article  CAS  PubMed  Google Scholar 

  34. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Chang’an District, Shijiazhuang, 050011, China

    Feng Gao, Tao Wang, Zefeng Zhang, Rui Wang, Yang Guo & Junfeng Liu

Authors
  1. Feng Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zefeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yang Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junfeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junfeng Liu.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

An erratum to this article is available at http://dx.doi.org/10.1007/s13277-017-5487-6.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, F., Wang, T., Zhang, Z. et al. RETRACTED ARTICLE: Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144. Tumor Biol. 37, 15535–15541 (2016). https://doi.org/10.1007/s13277-015-3866-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3866-4

Keywords

Search

Navigation